A phospholipid-based formulation for the treatment of airway inflammation in chronic respiratory diseases-Reference-Cited by-同舟云学术

A phospholipid-based formulation for the treatment of airway inflammation in chronic respiratory diseases

Published:2020-12 Issue: Volume:157 Page:47-58
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Komalla Varsha,Allam Venkata Sita Rama Raju,Kwok Philip Chi Lip,Sheikholeslami Behjat,Owen Louisa,Jaffe Adam,Waters Shafagh A,Mohammad Shiva,Oliver Brian Gregory,Chen Hui,Haghi Mehra

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference67 articles.

1. Chronic respiratory diseases and lung cancer research: a perspective from the European Union

2. Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis

3. Autophagy and inflammation in chronic respiratory disease

4. Airway Inflammation in Cystic Fibrosis

5. Mucociliary clearance: pathophysiological aspects

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of beta glucan coating on controlled release, bioaccessibility, and absorption of β-carotene from loaded liposomes;Food & Function;2024

2. Liposomes for the Management of Allergic Airway Diseases;Understanding Allergic Airway Diseases;2024

3. Microgel delivery systems of functional substances for precision nutrition;Advances in Food and Nutrition Research;2024

4. Recent advances in nanoparticle applications in respiratory disorders: a review;Frontiers in Pharmacology;2023-07-19

5. Comparing Cytology Brushes for Optimal Human Nasal Epithelial Cell Collection: Implications for Airway Disease Diagnosis and Research;Journal of Personalized Medicine;2023-05-21